| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.02 |